Element Biosciences’ cover photo
Element Biosciences

Element Biosciences

Biotechnology Research

San Diego, California 54,630 followers

Opening the world of biology to new possibilities

About us

Element Biosciences is a life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries.

Website
https://www.elementbiosciences.com
Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
San Diego, California
Type
Privately Held
Founded
2017
Specialties
Next-Generation Sequencers, DNA, and Biotechnology

Locations

  • Primary

    10055 Barnes Canyon Rd

    Suite 100

    San Diego, California 92121, US

    Get directions

Employees at Element Biosciences

Updates

  • During our 5th annual Day of Giving, Element employees and industry colleagues came together across multiple volunteer events to support our local community and make a meaningful impact. 📦 Volunteers partnered with Feeding San Diego to assemble 349 care packages in just two hours, helping provide breakfast and lunch to children throughout San Diego County during the summer months. 🩸 At our blood drive with the San Diego Blood Bank, employees donated 35 units of blood, enough to help save up to 105 lives. Even more inspiring, five team members donated blood for the very first time, and our drive had the largest turnout of the ten blood drives held that day. A huge thank you to everyone who volunteered their time, energy, and expertise. Your commitment to serving our community reflects the spirit of collaboration, curiosity, and impact that drives us every day. #DayofGiving

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • In June 2022, we shipped our first AVITI™ system. Four years later, our technologies are helping power discoveries around the world, from North America to Europe, Asia, and beyond. While a lot has changed since that first shipment, one thing hasn't: the customers who took a chance on us, partnered with us, and helped shape what Element is today. As we celebrate this milestone, we're grateful for the customers who have stuck with us from the beginning, and those who joined us more recently. Hear from a few of them below. ⬇️ #AVITI #AVITI24 #Sequencing #Multiomics

  • How can multimodal readouts improve pooled CRISPR screening workflows? 🧬 ⏳ Last chance to register! Our GEN webinar with Tilmann Buerckstuemmer, PhD from Myllia Biotechnology is happening today. Discover how pooled CRISPR screening combined with imaging on the AVITI24™ platform is shedding new light on NF-κB signaling and the regulatory roles of chromatin-modifying complexes. 🔬 Key topics include: Strategies for linking CRISPR perturbations to multiomic readouts to add depth and confidence Identification of chromatin modifying complexes in regulating NF-κB signaling How this approach supports mechanism-of-action studies and enables identification of both positive and negative regulators of signaling pathways Don't wait — secure your spot now: https://bit.ly/4uenMJL. #CRISPRScreening #Genomics #Multiomics #AVITI24

  • We’re still going strong at EACR and today is your last chance to stop by booth #89! 🎉 Come talk sequencing and multiomics with the Element team. Whether you're working in clinical research, drug discovery, or spatial workflows, our platforms are built to give cancer researchers the data quality and flexibility they need to move science forward. 🔬 We'd love to hear about your research and explore what's possible together. See you at booth #89! 👋 #EACR2026 #Sequencing #Multiomics

    • No alternative text description for this image
  • We are thrilled to announce our Series E round of financing, which includes $175 million from Samsung Electronics. "This financing represents a powerful vote of confidence in our vision, our technology, and our team's ability to execute. At a time when many life science companies continue to face significant market challenges, the support of both new and existing investors validates the progress we have made in building a differentiated portfolio of products and bringing them successfully to customers." - Molly He, CEO and Co-Founder of Element This new capital directly supports the commercialization and adoption of our growing ecosystem of genomic and multiomic technologies, including AVITI™, VITARI™, upcoming tissue applications on AVITI24™, and AVITI Dx™. Most importantly, it enables us to accelerate our mission of empowering researchers with transformative technologies that advance scientific discovery, support the future of precision medicine, and ultimately improve human health. Learn more: https://bit.ly/4fAEkrI. #AVITI #AVITI24 #VITARI

    • No alternative text description for this image
  • ESHG 2026 is almost here! We’ll be at booth #258 all week talking about sequencing, multiomics, and new approaches for studying genetic variation and complex disease biology. Be sure to stop by our corporate satellite session where we’ll discuss high-throughput genomics, direct tissue sequencing, and real-world applications using Trinity™ targeted sequencing in clinical research workflows. 👋 If you’ll be in Gothenburg, stop by to meet our team. See our full schedule and book a meeting: https://bit.ly/4o0kPLy. #ESHG2026 #Genomics #Multiomics #Sequencing

    • No alternative text description for this image
  • The future of personalized genomics depends on seeing both copies of the genome clearly chromosome. 🧬 That’s where Strand-seq stands out. It supports chromosome-length haplotyping, structural variant detection, genome assembly scaffolding, and high-resolution mapping of sister chromatid exchanges—signals that are difficult or impossible to resolve with other approaches. In our latest blog, we highlight how Dr. Peter Lansdorp’s lab is using AVITI™ sequencing to reduce mis-indexing noise, restoring strand assignment accuracy while delivering the throughput needed for large experiments. ⚡ Read more: https://bit.ly/43byPbE. #Sequencing #AVITI #Genomics #Multiomics

    • No alternative text description for this image
  • 📍 EACR 2026 starts next week! We’ll be at booth #89 all week talking about cancer biology research workflows spanning sequencing, screening, and spatial applications. If you’re attending, stop by and say hi! 👋 And don’t miss our Industry Spotlight Session: 🎤 Revealing a Deeper View of Cancer with 5D Biology 📅 Monday, June 8, 2026 ⏰ 7:15 PM–7:30 PM 📍 Spotlight Theater, Exhibit Hall H See you in Budapest! https://bit.ly/49J6Of3 #EACR2026 #Sequencing #Multiomics #AVITI24 #AVITI

    • No alternative text description for this image
  • As a Staff Scientist on Element’s Product Applications team, Marty Flores works across customers, field support, product development, and training—helping ensure scientists have the resources and support they need to succeed. “As long as we can get the voice of the customer to people, there will be a response to it.” That mindset has made Marty a key bridge between customer feedback and product improvement. Whether supporting field teams, developing training resources, or helping teams understand customer needs, she plays an important role in making sure the voice of the customer is heard. At Element, innovation starts with listening. Interested in helping shape the future of genomics? Explore open roles: https://bit.ly/4sUOAxV. #BiotechInnovation #Sequencing #Multiomics

    • No alternative text description for this image

Similar pages

Browse jobs